Form 4: Vericel Corp Executive Michael Halpin Reports Stock Transactions Following RSU Vesting
SEC Form 4
Chief Operating Officer Michael Halpin reports acquisition and disposal of Vericel Corp stock related to vesting of Restricted Stock Units (RSUs) and tax withholding.
Summary
- Michael Halpin, Chief Operating Officer of Vericel Corp, filed a Form 4 detailing changes in beneficial ownership.
- The transactions involve the vesting of Restricted Stock Units (RSUs) and the subsequent acquisition of common stock.
- Shares were also withheld by the issuer to cover tax obligations related to the RSU vesting.
- The reported transactions occurred between February 18, 2025, and February 19, 2025.
- Halpin acquired shares through RSU vesting at $0 and disposed of shares to cover tax obligations at $57.28 and $57.78.
- Following these transactions, Halpin directly owns 12,775 shares of Vericel Corp common stock.
Sentiment
Score: 6
Explanation: The document is neutral, reporting standard transactions related to executive compensation. There is no indication of positive or negative sentiment.
Positives
- The vesting of RSUs indicates a form of compensation and alignment of the executive's interests with the company's performance.
Negatives
- The disposal of shares to cover tax obligations, while standard, slightly reduces the executive's holdings.
Risks
- There are no specific risks explicitly mentioned in this document.
Future Outlook
The document indicates future vesting dates for remaining RSUs on February 17, 2026, February 18, 2026 and February 17, 2027.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company.
Comparison to Industry Standards
- Executive compensation packages often include RSUs to align management's interests with shareholders, a common practice across publicly traded companies.
- The vesting schedules and tax withholding practices are standard procedures in line with industry norms.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| February 17, 2023 | Date of RSU grant, with remaining RSUs vesting on February 17, 2026, and February 17, 2027. |
| February 18, 2022 | Date of RSU grant, with remaining RSUs vesting on February 18, 2026. |
| February 18, 2025 | Date of RSU vesting and stock transactions. |
| February 19, 2021 | Date of RSU grant. |
| February 19, 2025 | Date of RSU vesting and stock transactions. |
| February 20, 2025 | Date of Form 4 filing. |
| February 17, 2026 | Future vesting date for remaining RSUs. |
| February 18, 2026 | Future vesting date for remaining RSUs. |
| February 17, 2027 | Future vesting date for remaining RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.